Varying outcomes of triple-negative breast cancer in different age groups–prognostic value of clinical features and proliferation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7217
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Varying outcomes of triple-negative breast cancer in different age groups–prognostic value of clinical features and proliferation ; volume:196 ; number:3 ; day:19 ; month:10 ; year:2022 ; pages:471-482 ; date:12.2022
Breast cancer research and treatment ; 196, Heft 3 (19.10.2022), 471-482, 12.2022
- Creator
-
Vihervuori, H.
Korpinen, K.
Autere, T. A.
Repo, H.
Talvinen, K.
Kronqvist, P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10549-022-06767-1
- URN
-
urn:nbn:de:101:1-2023011821125664066785
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vihervuori, H.
- Korpinen, K.
- Autere, T. A.
- Repo, H.
- Talvinen, K.
- Kronqvist, P.
- SpringerLink (Online service)
Other Objects (12)
Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells
Metastatic Triple-Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells
WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer
Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer
AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells
miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer
Cinobufacini Injection Inhibits the Proliferation of Triple-Negative Breast Cancer Through the Pin1-TAZ Signaling Pathway
MicroRNA signatures in triple-negative breast cancer
Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells
Metastatic Triple-Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells
WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer
Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer
AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells
miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer
Cinobufacini Injection Inhibits the Proliferation of Triple-Negative Breast Cancer Through the Pin1-TAZ Signaling Pathway
MicroRNA signatures in triple-negative breast cancer
Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells
Metastatic Triple-Negative Breast Cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Protein kinase C inhibitor chelerythrine selectively inhibits proliferation of triple-negative breast cancer cells
WNT10B/β‐catenin signalling induces HMGA2 and proliferation in metastatic triple‐negative breast cancer
Key regulator PNPLA8 drives phospholipid reprogramming induced proliferation and migration in triple-negative breast cancer
AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer
Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells
miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer
Cinobufacini Injection Inhibits the Proliferation of Triple-Negative Breast Cancer Through the Pin1-TAZ Signaling Pathway